MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX

REFERENCE

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29.
   PubMed Web of Science ®Google Scholar
• van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet 2011;378:1741–1755.
   PubMed Web of Science ®Google Scholar
• Roberti A, La Sala D, Cinti C. Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective. J Cell Physiol 2006;207:571–581.
   PubMed Web of Science ®Google Scholar
• Govindan R, Page N, Morgensztern D, Read W, Tierney R, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24: 4539–4544.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics. Oncogene 2008;27(Suppl 2):S52–S57.
   PubMedGoogle Scholar
• Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005–1017.
   PubMed Web of Science ®Google Scholar
• Chen P, Zeng M, Zhao Y, Fang X. Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling. Oncol Rep. 2014
   Web of Science ®Google Scholar
• Golubovskaya VM, Sumbler B, Ho B, Yemma M, Cance WG. MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells. Anticancer Agents Med Chem 2014;14:18–28.
   PubMed Web of Science ®Google Scholar
• Han L, Zhang G, Zhang N, Li H, Liu Y, et al. Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer. Med Oncol 2014;31:129.
   PubMed Web of Science ®Google Scholar
• Lal A, Pan Y, Navarro F, Dykxhoorn DM, Moreau L, et al. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009;16:492–498.
   PubMed Web of Science ®Google Scholar
• Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci U S A 2010;107:1506–1511.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wan G, Mlotshwa S, Vance V, Berger FG, et al. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res 2010;70:7176–7186.
   Google Scholar
• Pothof J, Verkaik NS, van IW, Wiemer EA, Ta VT, et al. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 2009;28:2090–2099.
   PubMed Web of Science ®Google Scholar
• Yang H, Tang Y, Guo W, Du Y, Wang Y, et al. Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells. Tumour Biol 2014;35:6557–6565.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang JW, Li M, Cavenee WK, Mitchell PS, et al. MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res 2011;9: 1100–1111.
   PubMed Web of Science ®Google Scholar
• Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;10:38–47.
   PubMed Web of Science ®Google Scholar
• Zhao G, Cai C, Yang T, Qiu X, Liao B, et al. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 2013;8:e53906.
   PubMed Web of Science ®Google Scholar
• Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem 2003;278:20303–20312.
   PubMed Web of Science ®Google Scholar
• Gangopadhyay NN, Luketich JD, Opest A, Landreneau R, Schuchert MJ. PARP inhibitor activates the intrinsic pathway of apoptosis in primary lung cancer cells. Cancer Invest 2014;32:339–348.
   PubMed Web of Science ®Google Scholar
• Qu A, Wang H, Li J, Wang J, Liu J, et al. Biological effects of (125)i seeds radiation on A549 lung cancer cells: G2/M arrest and enhanced cell death. Cancer Invest 2014;32:209–217.
   PubMed Web of Science ®Google Scholar
• Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433–439.
   PubMed Web of Science ®Google Scholar
• Dickey JS, Redon CE, Nakamura AJ, Baird BJ, Sedelnikova OA, et al. H2AX: functional roles and potential applications. Chromosoma 2009;118:683–692.
   PubMedGoogle Scholar
• Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858–5868.
   PubMed Web of Science ®Google Scholar
• Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005;123:1213–1226.
   PubMed Web of Science ®Google Scholar
• Lukas C, Melander F, Stucki M, Falck J, Bekker-Jensen S, et al. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J 2004;23:2674–2683.
   PubMed Web of Science ®Google Scholar
• Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell 2006;21:187–200.
   PubMed Web of Science ®Google Scholar
• Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci U S A 2002;99:8173–8178.
   PubMed Web of Science ®Google Scholar
• Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, et al. Genomic instability in mice lacking histone H2AX. Science 2002;296:922–927.
   PubMed Web of Science ®Google Scholar
• Matthaios D, Hountis P, Karakitsos P, Bouros D, Kakolyris S. H2AX a promising biomarker for lung cancer: a review. Cancer Invest 2013;31:582–599.
   PubMed Web of Science ®Google Scholar
• Ye XW, Yu H, Jin YK, Jing XT, Xu M, et al. miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells. Clin Respir J 2014; doi:10.1111/crj.12100.
   Web of Science ®Google Scholar
• Long L, Huang G, Zhu H, Guo Y, Liu Y, et al. Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med 2013;11:275.
   PubMed Web of Science ®Google Scholar
• Santarpia L, Calin GA, Adam L, Ye L, Fusco A, et al. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer 2013;20:809–823.
   PubMed Web of Science ®Google Scholar
• Kozinn SI, Harty NJ, Delong JM, Deliyiannis C, Logvinenko T, et al. MicroRNA profile to predict gemcitabine resistance in bladder carcinoma cell lines. Genes Cancer 2013;4:61–69.
   PubMedGoogle Scholar
• Chakrabarti M, Banik NL, Ray SK. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo. Exp Cell Res 2013;319:1575–1585.
   PubMed Web of Science ®Google Scholar
• Chatzimichail E, Matthaios D, Bouros D, Karakitsos P, Romanidis K, et al. gamma-H2AX: a novel prognostic marker in a prognosis prediction model of patients with early operable non-small cell lung cancer. Int J Genomics 2014;2014:160236.
   PubMed Web of Science ®Google Scholar
• Djuzenova CS, Elsner I, Katzer A, Worschech E, Distel LV, et al. Radiosensitivity in breast cancer assessed by the histone gamma-H2AX and 53BP1 foci. Radiat Oncol 2013;8:98.
   PubMed Web of Science ®Google Scholar
• Doai M, Watanabe N, Takahashi T, Taniguchi M, Tonami H, et al. Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using gamma-H2AX foci of DNA damage in lymphocytes. Ann Nucl Med 2013;27:233–238.
   PubMed Web of Science ®Google Scholar
• van Oorschot B, Hovingh SE, Rodermond H, Guclu A, Losekoot N, et al. Decay of gamma-H2AX foci correlates with potentially lethal damage repair in prostate cancer cells. Oncol Rep 2013;29:2175–2180.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014;42:D68–D73.
   PubMed Web of Science ®Google Scholar
• Park SY, Jeong HJ, Yang WM, Lee W. Implications of microRNAs in the pathogenesis of diabetes. Arch Pharm Res 2013;36:154–166.
   PubMed Web of Science ®Google Scholar
• Aranda JF, Madrigal-Matute J, Rotllan N, Fernandez-Hernando C. MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med 2013;64: 31–39.
   PubMed Web of Science ®Google Scholar
• Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 2013;128:2026–2038.
   PubMed Web of Science ®Google Scholar
• Jansen F, Yang X, Nickenig G, Werner N, Vasa-Nicotera M. Role, function and therapeutic potential of microRNAs in vascular aging. Curr Vasc Pharmacol. 2013
   Web of Science ®Google Scholar
• Lee HM, Nguyen DT, Lu LF. Progress and challenge of microRNA research in immunity. Front Genet 2014;5:178.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang H, Zhao M, Lv Z, Zhang X, et al. MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. Cell Physiol Biochem 2013;31:56–65.
   PubMed Web of Science ®Google Scholar